Passive surveillance of infectious diseases with a high percentage of asymptomatic cases or long incubation periods does not reflect the actual epidemiological status of the disease. In diseases with long incubation periods such as acquired immunodeficiency syndrome (AIDS) and chronic viral hepatitis, passive case report does not depicts the current infection dynamics (Alary & Castel 1990 ). Thus, a prolonged multi-strategic surveillance system is necessary to get a reliable idea of disease trends. The World Health Organization (WHO) recommends that human immunodeficiency virus (HIV) surveillance should be done trough periodical prevalence studies in a specific population. An isolated prevalence study will reveal HIV status in that population at a single moment, but the evaluation of serial prevalence studies can indicate the epidemics trend (WHO 1992) . This strategy is known as sentinel surveillance and can be applied to different population settings [such as in-hospital Matuszak et al. 1990 , McLaws et al. 1990 , Pappaioanou et al. 1990 , Gwinn et al. 1991 , Tappin et al. 1991 , Kigadye et al. 1993 , Alary et al. 1994 , Canosa et al. 1997 , Siedler et al. 1998 , Amar et al. 1999 .
The Brazilian HIV Sentinel Surveillance Project started in May 1992, and since 1997 it is being performed in STD clinics, emergency care units, and with intravenous drug users, and childbearing women with a convenience sample. In 2000, a new random sampling strategy was adopted for childbearing women looking for more representative data. Cluster sampling method was established with two phases, starting with the selection of cities throughout the country and then selecting hospitals with at least 1000 childbirths per year in these cities. One hundred and fifty hospitals were randomly selected to have 120 samples each. Detailed discussion of this methodology has been published elsewhere (Szwarcwald & Carvalho 2000) .
The state of Minas Gerais, Brazil, has a well established Neonatal Screening Programme (NSP) covering all municipalities and 96% of newborns, with approximately 24,000 children screened per month (Serjeant 2000) . Blood samples from heel sticks are collected in filter paper after the fifth day of birth and sent to a Central Laboratory (Núcleo de Pesquisa em Apoio Diagnóstico -Nupad) at the Federal University of Minas Gerais by regular mail. The samples are tested for sickle cell anemia, congenital hypothyroidism, cystic fibrosis and phenylketonuria and the results are available 14 days after blood collection. Many other tests can be done with dried blood spots (DBS) (Aebischer et al. 1990) , including serologic and molecular tests for HIV, hepatitis B virus, and hepatitis C virus (Gascon et al. 1988 , Varnier et al. 1988 , Cassol et al. 1991 , Gupta et al. 1992 , Nyambi et al. 1994 , Comeau et al. 1996 , Biggar et al. 1997 , Tappin et al. 1998 , Panteleeff et al. 1999 , Parker et al. 1999 , Singh et al. 2000 , Proietti et al. 2001 , Rollins et al. 2002 . DBS tests for infectious diseases have been already validated and have shown good correlation with traditional serological tests (Parry et al. 1992 , Pappaioanou et al. 1993 , Beck et al. 2001 . Newborns start to produce their own antibodies by the second month of age and the antibodies identified shortly after birth are usually maternal. Thus, it is possible to estimate the seroprevalence of infectious diseases among childbearing women by testing their newborn blood for antibodies.
Sentinel evaluations are crucial for public health decisions, but they are also very expensive and complex to implement. The use of an established NSP for this purpose can be simpler, cheaper, and more feasible than traditional methods.
The objectives of this study were to evaluate the feasibility and costs of infectious disease surveillance using dried blood spots collected for neonatal screening of metabolic diseases in the state of Minas Gerais, Brazil. This was accomplished through the comparison of HIV and HCV seroprevalence with previous Brazilian studies.
METHODS
Population -This was a transversal study in newborns from Minas Gerais who were included in NSP between December 2001 and June 2002. The NSP form included the date of collection and city of birth; mother age was not available. All tests were performed anonymously and unlinked. The project is in accordance with the Declaration of Helsinki (2000) and was approved by the Federal University of Minas Gerais Research Ethics Committee.
Sample-size -The Brazilian 2000 HIV Sentinel Surveillance found a national mean for HIV seroprevalence among childbearing women of 0.47%, with a 95% confidence interval (CI) of 0.362, 0.576 (Szwarcwald & Carvalho 2000) . Focaccia et al. (1998) observed a mean HCV prevalence of 1.5% in São Paulo metropolitan area in 1997. Based on theses two studies, the sample size was calculated according to statistical criteria for the prevalence estimation, namely an acceptable error at the 95% CI (Lemeshow et al. 1990 , Rosner 1995 , and tests costs using nQuery Advisor 4.0 ® software. Sample size for HIV were calculated to be representative for Minas Gerais micro-regions and considered the estimated number of children born in one month (approximately 24,000). For HCV, a representative sample for micro-regions was calculated and comprised 4200 children (95% confidence level, maximum error 0,014). Each one of the 66 micro-regions was considered a stratum and a stratified sample was calculated according to the number of screened children in each one. Cities with no data were excluded. The means of screened children were calculated according to NSP registers from January to August 2001.
Data collection and analysis -All tests for DBS were done at Nupad using Umelisa HIV 1+2 Recombinant Test and Umelisa HCV Test (Tecnosuma International, La Habana, Cuba), registered at Brazilian Ministry of Health. This HIV test has been already validated and used in a study of HIV prevalence among intravenous drug users by the Brazilian AIDS Programme (Proietti et al. 2001) . The HCV test, as far as we know, is yet to be validated in Brazil. All samples were tested for HIV(1+2) and HCV antibodies detection and the positive samples were re-tested with the same kit. Confirmatory tests for DBS were not available at this time. Afterwards, the whole consolidated results and tests costs were compared with the Brazilian Ministry of Health's 2000 Sentinel Study.
RESULTS
From the 24,905 ELISA tests for HIV-1+2, 61 were positive and seven borderline. For HCV, 4211 tests were done, 30 were positive and four borderline. Borderline results were discarded at analysis and micro-regions were grouped in 26 macro-regions. HIV seroprevalence varied from zero (observed in six macro-regions) to 0.81% with a mean of 0.25% and a 95% CI of 0.18, 0.31%. HCV seroprevalence varied from zero (observed in 11 macro-regions) to 2.86% with a mean of 0.71% and a 95% CI of 0.46, 0.97%. From a total of 26 macro-regions, 20 had at least one HIV positive test and 15 had at least one HCV positive test (Table I) . Figs 1 and 2 show the spatial distribution of HIV and HCV seroprevalence, respectively. Spatial distribution analysis showed higher seroprevalence of both HIV and HCV in macro-regions with known high injectable drug use, especially Uberlandia, Uberaba, and Passos or crossed by important interstate highways, as Itabira, Coronel Fabriciano, Governador Valadares, and Teofilo Otoni. 
DISCUSSION
Seroprevalence of HIV and HCV -There are few large studies on HIV and HCV seroprevalence in Brazil. One of them, the Brazilian 2000 HIV Sentinel Surveillance found a mean HIV seroprevalence among childbearing women of 0.47% and a 95% CI of 0.362, 0.576 for the country (Szwarcwald & Carvalho 2000) . For HCV infection, the largest population-based seroprevalence study based on 1059 persons was performed by Focaccia et al. (1998) in São Paulo metropolitan area, showing a seroprevalence ranging from 0 to 3.25% among persons between 15-49 years of age (Table II) , with no statistical differences between male and female.
Despite the apparent differences in the means, our results are practically very similar to the above-mentioned studies, when considering the confidence intervals (Table  III) . On the other hand, these studies are probably not comparable as their population and sampling method were different and were done in different times. Concerning HIV, we evaluated regionally the same population (childbearing women) but two years later than the Ministry of Health study (Szwarcwald & Carvalho 2000) , which represents the national seroprevalence. In relation to Focaccia et al. (1998) HCV seroprevalence study, there is a fiveyear gap and their data represent both male and female from São Paulo metropolitan area.
There was a wide variation in HIV and HCV prevalence among Minas Gerais macro-regions, as depicted in Figs 1 and 2. HIV is not only more disseminated throughout the state but it is still spreading centrifugally from large to small towns, mainly due to unprotected sexual contact and had a more pronounced variation than HCV. Nevertheless there was an overlapping of high prevalence areas in Western, Central, and Northeastern regions. Those differences in prevalence maybe due to a later introduction of HCV among the population evaluated, and to differences in the transmission mode of the virus. As intravenous drug use is currently considered the main transmission mode of HCV this characteristic could limit its dissemination to regions where these drugs are more easily available. It is thus remarkable that the prevalence for HCV was still higher than for HIV, as showed in other studies.
Feasibility and costs -The total cost for the 2003 Brazilian HIV Sentinel Surveillance was estimated at US$ 280,000.00 or US$ 8.5 per sample tested for HIV, HBV, HCV, and syphilis. About 45% of this cost was for local personal training and wages; 20% for laboratorial supplies (tubes, vacutainers, and needles); samples and laboratory supplies transportation; and 35% for the serologic kits. Our study had a total cost of R$ 30,600.00 or US$ 1.27 per sample tested for HIV and HCV. If all serological tests are included, as in Brazilian Sentinel Surveillance Program, our cost per sample would be US$ 3.10, 36.5% of the Brazilian Program. The NSP-based surveillance has practically no extra costs with personal training and wages, laboratory supplies and sample transportation. As the infrastructure is already set, the only additional costs are testing expenses (kits plus laboratory time) and data analyses, making the procedure considerably cheaper and practical. DBS may be also useful for epidemiological studies in other populations and/or for diagnosis purposes in remote areas, avoiding the technical hurdles. Of course in this situation the actual cost per sample will be higher than in places with an already established NSP, but probably worth considering as it would avoid the expenses and hurdles related to drawing, stocking, and transporting blood samples.
It must also be emphasized that NSP is not appropriate for routine HIV infection diagnosis among childbearing women as it would be unethical to have this diagnosis only after birth. In this case, it makes more sense to increase efforts to have HIV tests available early in pregnancy, as is the Brazilian Ministry of Health policy.
Sampling strategy in the usual sentinel study is quite different from NSP-based studies. Sentinel study uses cluster sampling, which has a higher risk of selection bias. As the Brazilian Sentinel Program defines hospitals as sample unit, the chances of selecting a hospital that is a reference for HIV-infected childbearing women is not small, consequently overestimating HIV seroprelavence. NSP sampling is easier to perform and has a higher chance of being representative of the target population, as it is a simple random sampling. On the other hand, NSP needs a prior existing structure and a good coverage of population to be representative. Another drawback is that if maternal antibodies levels in newborn blood are very low there will be a chance of false-negative tests, which would underestimate the seroprevalence. The results point to the conclusion that dried blood spots are simple and inexpensive tool for the surveillance of many infectious diseases in countries with an established Neonatal Screening Network, such as Brazil. It may also become a practical surveillance strategy, albeit it is still necessary to compare its results in a concomitant study with the usual sentinel methodology to validate it for infectious disease surveillance, as HIV and HCV.
